Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000179745 | SCV000232044 | uncertain significance | not provided | 2015-02-23 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000670818 | SCV000795722 | uncertain significance | Neuronal ceroid lipofuscinosis 1 | 2017-11-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000670818 | SCV001202337 | pathogenic | Neuronal ceroid lipofuscinosis 1 | 2024-09-30 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 241 of the PPT1 protein (p.Ser241Leu). This variant is present in population databases (rs746043871, gnomAD 0.01%). This missense change has been observed in individual(s) with neuronal ceroid lipofuscinosis (PMID: 22387303, 23374165; internal data). ClinVar contains an entry for this variant (Variation ID: 198413). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt PPT1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Institute of Human Genetics, |
RCV000670818 | SCV004100702 | likely pathogenic | Neuronal ceroid lipofuscinosis 1 | 2023-09-19 | criteria provided, single submitter | clinical testing | Criteria applied: PS4_MOD,PM1,PM2_SUP,PP3 |
Baylor Genetics | RCV000670818 | SCV004204146 | likely pathogenic | Neuronal ceroid lipofuscinosis 1 | 2024-03-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000670818 | SCV005647456 | likely pathogenic | Neuronal ceroid lipofuscinosis 1 | 2024-05-06 | criteria provided, single submitter | clinical testing |